- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/04 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Patent holdings for IPC class C07D 233/04
Total number of patents in this class: 45
10-year publication summary
|
4
|
1
|
3
|
3
|
3
|
2
|
2
|
1
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cornell University | 3384 |
3 |
| Massachusetts Institute of Technology | 10196 |
2 |
| Dow AgroSciences LLC | 1198 |
2 |
| Coral Sunscreen Pty Ltd | 5 |
2 |
| Kirin Holdings Company, Limited | 248 |
2 |
| GPCP IP Holdings LLC | 1545 |
2 |
| Eccogene Inc. | 11 |
2 |
| The Regents of the University of California | 20534 |
1 |
| Allergan, Inc. | 2214 |
1 |
| Toshiba Corporation | 12691 |
1 |
| Bayer MaterialScience AG | 739 |
1 |
| California Institute of Technology | 4014 |
1 |
| The Johns Hopkins University | 5819 |
1 |
| The Trustees of Columbia University in the City of New York | 3618 |
1 |
| Aditya Birla Science and Technology Company Limited | 14 |
1 |
| BIAL - Portela & CA, S.A. | 213 |
1 |
| Capella Therapeutics, Inc. | 17 |
1 |
| Harcros Chemicals Inc. | 33 |
1 |
| Hexion Inc. | 230 |
1 |
| Karos Pharmaceuticals, Inc. | 3 |
1 |
| Other owners | 17 |